Related Experiment Video
Updated: Oct 15, 2025

06:10
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
Published on: December 8, 2023
1.9K
Stimulating Tear Production: Spotlight on Neurostimulation
Michael D Yu1, Ji Kwan Park2, Andrea L Kossler1
1Oculoplastic Surgery and Orbital Oncology Service, Byers Eye Institute, Stanford University, Palo Alto, CA, USA.
Clinical Ophthalmology (Auckland, N.Z.)
|October 28, 2021
Summary
Neurostimulation offers a promising new approach for treating dry eye disease (DED) by targeting the lacrimal functional unit (LFU). This method shows potential in increasing tear production and alleviating DED symptoms.
Area of Science:
- Ophthalmology
- Neuroscience
- Medical Technology
Background:
- Dry eye disease (DED) impacts a significant portion of the global population, with current treatments yielding variable results.
- The lacrimal functional unit (LFU) is crucial for maintaining ocular surface hydration.
- Understanding the neuroanatomy and pathophysiology of DED is key to developing novel therapies.
Purpose of the Study:
- To review the neuroanatomical and pathophysiological basis for using neurostimulation in DED treatment.
- To explore various neurostimulatory approaches for managing DED.
- To assess the current evidence and future potential of neurostimulation for DED.
Main Methods:
- Literature review of studies on DED, LFU neuroanatomy, and neurostimulation techniques.
- Analysis of different neurostimulatory modalities, including implanted, external, and chemical methods.
- Evaluation of existing research on the efficacy of neurostimulation in DED.
Main Results:
- Neurostimulation targets the LFU, offering a viable alternative to traditional DED therapies.
- Studies indicate that neurostimulation can increase tear volume and improve dry eye symptoms.
- Various approaches, from implanted to external devices and chemical methods, are being explored.
Conclusions:
- Neurostimulation presents a promising therapeutic avenue for DED.
- Further research is necessary to fully understand and optimize the potential of neurostimulation for DED treatment.
- This approach may offer a novel solution for the large population affected by dry eye disease.

